A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 145,868 shares of PFE stock, worth $3.67 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
145,868
Previous 146,458 0.4%
Holding current value
$3.67 Million
Previous $4.1 Million 3.03%
% of portfolio
0.69%
Previous 0.68%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$27.7 - $31.39 $16,343 - $18,520
-590 Reduced 0.4%
145,868 $4.22 Million
Q2 2024

Jul 26, 2024

SELL
$25.26 - $29.6 $45,240 - $53,013
-1,791 Reduced 1.21%
146,458 $4.1 Million
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $218,899 - $251,367
-8,455 Reduced 5.4%
148,249 $4.11 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $1.45 Million - $1.88 Million
-55,340 Reduced 26.1%
156,704 $4.51 Million
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $42,198 - $49,325
-1,315 Reduced 0.62%
212,044 $7.03 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $284,950 - $329,681
-7,889 Reduced 3.57%
213,359 $7.83 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $8,626 - $11,230
-219 Reduced 0.1%
221,248 $9.03 Million
Q4 2022

Jan 18, 2023

SELL
$41.75 - $54.5 $12,650 - $16,513
-303 Reduced 0.14%
221,467 $0
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $16,241 - $20,124
355 Added 0.16%
221,770 $11.5 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $641,327 - $950,661
15,521 Added 7.54%
221,415 $13.1 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $199,547 - $256,335
5,084 Added 2.53%
205,894 $8.86 Million
Q1 2021

Sep 09, 2021

SELL
$33.49 - $37.77 $3,683 - $4,154
-110 Reduced 0.05%
200,810 $7.28 Million
Q4 2020

Sep 09, 2021

SELL
$33.47 - $42.56 $4,451 - $5,660
-133 Reduced 0.07%
200,920 $7.4 Million
Q3 2020

Sep 09, 2021

SELL
$31.75 - $37.25 $15,557 - $18,252
-490 Reduced 0.24%
201,053 $7.38 Million
Q2 2020

Sep 09, 2021

SELL
$30.12 - $36.54 $1.58 Million - $1.92 Million
-52,453 Reduced 20.65%
201,543 $6.59 Million
Q1 2020

Sep 09, 2021

SELL
$27.03 - $38.62 $12,163 - $17,379
-450 Reduced 0.18%
253,996 $8.29 Million
Q4 2019

Sep 09, 2021

SELL
$32.92 - $37.36 $329 - $373
-10 Reduced -0.0%
254,446 $9.97 Million
Q3 2019

Nov 20, 2019

SELL
$32.49 - $42.13 $36,226 - $46,974
-1,115 Reduced 0.44%
254,456 $9.14 Million
Q1 2019

May 16, 2019

SELL
$37.5 - $41.2 $22,125 - $24,308
-590 Reduced 0.23%
255,571 $10.9 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $46,240 - $52,719
-1,202 Reduced 0.47%
256,161 $11.2 Million
Q2 2018

Aug 15, 2018

SELL
$32.98 - $35.16 $83,967 - $89,517
-2,546 Reduced 0.98%
257,363 $9.34 Million
Q1 2018

May 16, 2018

SELL
$31.91 - $37.02 $8,615 - $9,995
-270 Reduced 0.1%
259,909 $9.22 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $199,426 - $211,598
5,996 Added 2.36%
260,179 $9.42 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $118,048 - $130,043
3,808 Added 1.52%
254,183 $9.07 Million
Q2 2017

Aug 24, 2017

BUY
N/A
250,375
250,375 $8.41 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.